Literature DB >> 15551210

Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects.

Mark R Sannes1, Michael A Kuskowski, Krista Owens, Abby Gajewski, James R Johnson.   

Abstract

BACKGROUND: Escherichia coli is the most common cause of gram-negative bloodstream infections, causing an estimated 40,000 deaths from sepsis each year in the United States. The present study sought to determine specifically which virulence factors (VFs) and phylogenetic groups of E. coli are epidemiologically associated with bacteremia.
METHODS: E. coli isolates from 63 veterans with bacteremia and rectal isolates from 71 matched uninfected control subjects were compared both for phylogenetic group and for the presence of VFs and O antigens.
RESULTS: Bacteremia isolates exhibited a significantly greater prevalence of most VFs studied. In multivariate logistic regression analysis, ompT (outer membrane protein T) was the strongest VF predictor of bacteremia (P<.001). Despite the concentration of most individual VFs within group B2, bacteremia and rectal isolates differed little by phylogenetic distribution, a finding explained by the greater prevalence of VFs among bacteremia isolates than rectal isolates within groups B2 and D.
CONCLUSIONS: Although phylogenetic group partially corresponds with virulence potential in E. coli bacteremia, VFs are more-powerful predictors of pathogenic potential. Bacteremia isolates exhibit an arsenal of VFs that distinguishes them from rectal isolates from uninfected hosts, which makes these differences attractive potential targets in vaccine or drug development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15551210     DOI: 10.1086/425984

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  41 in total

1.  Distribution of human commensal Escherichia coli phylogenetic groups.

Authors:  Jannine K Bailey; Jeremy L Pinyon; Sashindran Anantham; Ruth M Hall
Journal:  J Clin Microbiol       Date:  2010-07-07       Impact factor: 5.948

2.  Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype.

Authors:  James R Johnson; Stephen B Porter; George Zhanel; Michael A Kuskowski; Erick Denamur
Journal:  Infect Immun       Date:  2012-02-06       Impact factor: 3.441

Review 3.  Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?

Authors:  Robert S Munford
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

4.  Prevalence and persistence of Escherichia coli strains with uropathogenic virulence characteristics in sewage treatment plants.

Authors:  E M Anastasi; B Matthews; A Gundogdu; T L Vollmerhausen; N L Ramos; H Stratton; W Ahmed; M Katouli
Journal:  Appl Environ Microbiol       Date:  2010-07-09       Impact factor: 4.792

5.  Inhibitor-resistant TEM- and OXA-1-producing Escherichia coli isolates resistant to amoxicillin-clavulanate are more clonal and possess lower virulence gene content than susceptible clinical isolates.

Authors:  Jesús Oteo; Juan José González-López; Adriana Ortega; J Natalia Quintero-Zárate; Germán Bou; Emilia Cercenado; María Carmen Conejo; Luis Martínez-Martínez; Ferran Navarro; Antonio Oliver; Rosa M Bartolomé; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

6.  Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach.

Authors:  Swaine L Chen; Chia-Seui Hung; Jian Xu; Christopher S Reigstad; Vincent Magrini; Aniko Sabo; Darin Blasiar; Tamberlyn Bieri; Rekha R Meyer; Philip Ozersky; Jon R Armstrong; Robert S Fulton; J Phillip Latreille; John Spieth; Thomas M Hooton; Elaine R Mardis; Scott J Hultgren; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

7.  Virulence potential of Escherichia coli isolates from skin and soft tissue infections.

Authors:  Ziva Petkovsek; Kristina Elersic; Marija Gubina; Darja Zgur-Bertok; Marjanca Starcic Erjavec
Journal:  J Clin Microbiol       Date:  2009-04-08       Impact factor: 5.948

8.  Genetic relatedness and virulence gene profiles of Escherichia coli strains isolated from septicaemic and uroseptic patients.

Authors:  N L Ramos; M L Saayman; T A Chapman; J R Tucker; H V Smith; J Faoagali; J C Chin; A Brauner; M Katouli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-09-08       Impact factor: 3.267

9.  Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and Urovirulent E. coli strains among dogs and cats within a household.

Authors:  James R Johnson; Sybille Miller; Brian Johnston; Connie Clabots; Chitrita Debroy
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

10.  Prevalence of ST131 among fluoroquinolone-resistant Escherichia coli obtained from rectal swabs before transrectal prostate biopsy.

Authors:  Michael A Liss; Ellena M Peterson; Brian Johnston; Kathryn Osann; James R Johnson
Journal:  Urology       Date:  2013-01-17       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.